<?xml version="1.0"?>
<rss version="2.0">
  <channel>
    <title>RxPG News : Daclizumab</title>
      <link>http://www.rxpgnews.com/</link>
      <description>Medical News and Information</description>
      <pubDate>Thu, 21 Aug 2008 02:00:28 PST</pubDate>
      <language>en-us</language>
      <item>
        <title>New insights into how anti-rejection drug daclizumab helps MS patients</title>
        <link>http://www.rxpgnews.com/daclizumab/New_insights_into_how_anti-rejection_drug_daclizum_3829_3829.shtml</link>
        <category>Daclizumab</category>
        <description>Discovery of the mechanism of a drug being tested for the treatment of multiple sclerosis (MS) has revealed that it&#39;s not only more effective than first thought, but might also help in the management of other autoimmune diseases, organ transplant rejection and even cancer.</description>
        <pubDate>Wed, 29 Mar 2006 06:47:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/daclizumab/New_insights_into_how_anti-rejection_drug_daclizum_3829_3829.shtml</guid>
      </item>
      <item>
        <title>Daclizumab is effective in reducing rejection in heart transplantation</title>
        <link>http://www.rxpgnews.com/daclizumab/Daclizumab_is_effective_in_reducing_rejection_in_h_3830_3830.shtml</link>
        <category>Daclizumab</category>
        <description>A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.</description>
        <pubDate>Thu, 30 Jun 2005 06:50:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/daclizumab/Daclizumab_is_effective_in_reducing_rejection_in_h_3830_3830.shtml</guid>
      </item>


  </channel>
</rss>
